JPRN-UMIN000051498
尚未招募
未知
Inhaled nitric oxide (iNO) therapy for preterm infants after 7 days of age: a scoping review - Inhaled nitric oxide (iNO) therapy for preterm infants after 7 days of age: a scoping review
概览
- 阶段
- 未知
- 干预措施
- 未指定
- 疾病 / 适应症
- Bronchopulmonary dysplasia (BPD), Pulmonary hypertension, Neonatal hypoxic respiratory failure
- 发起方
- Kitasato University
- 状态
- 尚未招募
- 最后更新
- 2年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- 未提供
排除标准
- •i) Infants born more than 37 weeks of gestational age ii) Initiation of iNO is before 7 days of life iii) Infants with congenital malformation syndrome and a chromosomal abnormality iv) Animal and in\-vitro studies
结局指标
主要结局
未指定
相似试验
进行中（未招募）
1 期
Pulsed, inhaled nitric oxide (iNO) for the treatment of patients with mild ormoderate corona virus disease (COVID-19)EUCTR2020-002394-94-BEDr. De Backer Wilfried BV6
已完成
不适用
eonatal ventilation with INhaled Nitric Oxide versus Ventilatory support withOut inhaled nitric oxide for severe respiratory failure: a randomised controlled trialRespiratory diseaseNeonatal DiseasesRespiratory failureISRCTN17821339Medical Research Council (MRC) (UK)160
已完成
2 期
Inhaled Nitric Oxide to Prevent and Treat Bronchopulmonary DysplasiaPulmonary DiseaseNCT01503801Fudan University400
终止
3 期
Early Inhaled Nitric Oxide for Respiratory Failure in NewbornsInfant, NewbornHypertension, PulmonaryPersistent Fetal Circulation SyndromePneumonia, AspirationRespiratory Distress Syndrome, NewbornRespiratory InsufficiencyNCT00005773NICHD Neonatal Research Network302
进行中（未招募）
1 期
Therapy with Inhaled Nitric Oxide for Patients Infected with Coronavirus Suffering form Lung FailureARDS caused by COVID-19 infectionTherapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]EUCTR2020-001329-30-ATMassachussetts General Hospital200